June 9-10 | Ocean Gateway, Portland, ME
2025 Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine
Accelerating Drug Development Through Responsible AI

About the Symposium
Where will the AI revolution take Pharmaceutical Science?
Our world increasingly relies on data and computing to create knowledge, to make critical decisions, and to better predict the future. Data science has emerged to support these data-driven activities by integrating and developing ideas, concepts, and tools from computer science, engineering, information science, statistics, and domain fields. Data science now drives fields as diverse as biology, astronomy, material science, political science, and medicine—not to mention vast tracts of the global economy, key government activities, and quotidian social and societal functions.
The pharmaceutical enterprise has been slower to respond, especially to the rapid developments in AI, but tectonic shifts are underway in approaches to the discovery, development, evaluation, registration, monitoring, and marketing of medicines for the benefit of patients and the health of the community.
While there is much discussion about the potential of AI and modern machine learning tools to transform the drug development paradigm, there is a growing recognition of the paucity of research about the opportunities, inevitable pitfalls and unintended consequences of the digital revolution in this important area of application. As we move toward personalized and truly evidence-based medicine, the use of AI and machine learning to optimize drug deployment raises a whole different set of challenges.
This forum is, therefore, expected to serve as a platform for distinguished statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine; to foster collaboration among industry, academia, regulatory agencies, and professional associations; and to propose recommendations with policy implications for proper implementation of AI in promoting public health.
Key Details
Conference Co-Chairs
Demissie Alemayehu, Pfizer Inc.
David Madigan, Northeastern University
Date & Time
June 9-10, 2025
Day 1: 12:00 pm-5:00 pm EDT
Day 2: 8:00 am-7:30 pm EDT
Location
Ocean Gateway
14 Ocean Gateway Pier
Portland, Maine 04101
Hotel
AC Hotel Portland Downtown/Waterfront, ME
158 Fore Street Portland, Maine, 04101
Reserve a room
Contact Us
For program-related queries, please reach out to:
Demissie Alemayehu demissie.alemayehu@pfizer.com
David Madigan office_of_the_provost@northeastern.edu
For all other inquiries, please contact: aipm@northeastern.edu
Day 1
Tutorials
Ocean Gateway
14 Ocean Gateway Pier, Portland, Maine 04101
Day 2
Meeting, Program
Ocean Gateway
14 Ocean Gateway Pier, Portland, Maine 04101
Reception
Roux Institute, Northeastern University
100 Fore Street, Portland, ME 04101
Keynote Speaker: Jeremy Forman
Vice President, Research & Development AI, Data, & Analytics
Pfizer Inc.
View Bio
A Special Fireside Chat with Robert Califf
Former Commissioner
Food and Drug Administration
Professor of Medicine
Duke University of Medicine
View Bio
Speakers
Our distinguished speakers represent the forefront of AI innovation in pharmaceutical medicine, bringing together leading experts from top research institutions, pharmaceutical companies, and regulatory agencies. From pioneering data scientists to experienced industry practitioners, these thought leaders will drive critical discussions about AI’s transformative potential in healthcare. Discover the full roster of our speakers and their groundbreaking contributions on our Speakers page.
Explore photos from the 2024 AIPM Symposium. Click on a photo below to expand it.